优先股及以公允价值计量的金融负债

港股IPO招股书披露先例 · 233 家公司,234 项

可转换可赎回优先股及附赎回权的金融工具,通常按公允价值计量并将变动计入损益,或确认为赎回负债,在往绩记录期间产生非现金公允价值亏损及相关利息。申请人一般于概要、风险因素及财务资料章节披露其计量方法、账面值及变动金额,说明相关变动属非现金性质,并解释该等负债将于上市时自动转换为普通股、重新分类至权益,或经赎回权终止及重组后终止确认。

2026-06-29Prospectus
易控智驾科技股份有限公司EACON Group Co., Ltd07687.HK

附优先权股份的公允价值变动及转换

During the Track Record Period, our fair value changes on financial liabilities at FVTPL amounted to RMB33.5 million, RMB66.1 million, and nil in 2023, 2024, 2025, respectively.

Financial Information · 第 219 页

Our fair value changes on financial liabilities at FVTPL increased by RMB32.6 million, or 97.3% from RMB33.5 million in 2023 to RMB66.1 million in 2024, primarily attributable to the fair value changes in our shares with preferred rights classified as financial liabilities, driven by adjustments in valuation assumptions related to our improving business outlook, higher projected performances, and increased probability of a liquidity event such as an initial public offering.

Financial Information · 第 225 页

In 2024, our financial position improved from net liabilities of RMB812.5 million as of December 31, 2023 to net assets of RMB260.0 million as of December 31, 2024, primarily attributable to the conversion of substantially all historical rounds of shares with preferred rights into ordinary shares of RMB1,415.7 million and additional capital contributions from shareholders, partially offset by a loss and total comprehensive expense of RMB390.6 million.

Summary · 第 7 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-06-29Application Proof

可转换可赎回优先股公平值亏损

We recorded fair value losses of convertible redeemable preferred shares of RMB73.0 million, RMB76.2 million and RMB147.8 million in 2023, 2024 and 2025, respectively, resulting from the increase in fair value of convertible redeemable preferred shares.

Financial Information · 第 227 页

On May 30, 2025, we reached an agreement with the holders of the convertible redeemable preferred shares that we repurchased 3,454,613 Series D Preferred Shares at a total consideration of USD24,000,000 in June 2025 and the holders would not exercise the redemption rights to request us to repurchase their outstanding Preferred Shares on or before December 31, 2026.

Financial Information · 第 244 页

We do not expect to recognize any further fair value gain or loss on convertible redeemable preferred shares in the future upon [REDACTED].

Financial Information · 第 244 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-06-26Application Proof
上海联泰科技股份有限公司Shanghai Union Technology Corporation

赎回负债逾5.8亿元并计提利息

As of December 31, 2023, 2024, 2025 and April 30, 2026, we had redemption liabilities of RMB515.9 million, RMB588.4 million, RMB580.5 million and RMB618.0 million, respectively.

Financial Information · 第 208 页

During the Track Record Period, we recorded interest on redemption liabilities of RMB42.2 million, RMB42.5 million and RMB41.8 million in 2023, 2024 and 2025, respectively.

Financial Information · 第 190 页

While we recorded net losses during the Track Record Period primarily due to interest on redemption liabilities, our business remains sustainable and is supported by substantial growth momentum.

Business · 第 128 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-06-25Application Proof
杭州灵卡科技股份有限公司Hangzhou Lygo Technology Co., Ltd.

可赎回股份公允价值亏损计入损益

We recorded losses from fair value changes of financial liabilities through profit or loss of RMB83.2 million, RMB12.3 million and RMB165.3 million in 2023, 2024 and 2025, respectively, primarily attributable to changes in the valuation of our Company.

Financial Information · 第 212 页

Our fair value loss on financial liabilities represents changes in the carrying amount of our equity share with redemption rights issued to pre-[REDACTED] investors.

Financial Information · 第 212 页

We do not expect to record any further fair value losses of financial liabilities at fair value through profit or loss upon the [REDACTED] as such issuance of equity shares with redemption rights will be re-designated and reclassified from liabilities to equity as a result of the termination of the redemption rights upon the [REDACTED].

Financial Information · 第 206 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-06-25Application Proof
维健国际控股集团有限公司WinHealth International Holding Group Company Limited

可赎回可转换优先股公允价值变动重大

Our fair value change in financial instruments issued to investors were RMB10.3 million, RMB47.4 million and RMB238.2 million, respectively, for the years ended December 31, 2023, 2024 and 2025.

Financial Information · 第 235 页

The fair values of the convertible redeemable preferred shares and convertible loans measured at fair value through profit or loss are determined using the valuation technique of hybrid approach, combining the discounted cash flow method, the backsolve method and the option-pricing method.

Financial Information · 第 223 页

These preferred shares will be reclassified from liabilities to equity as a result of the conversion into ordinary shares upon the [REDACTED]. Subsequently, we do not expect to record any further fair value change in financial instruments issued to investors.

Financial Information · 第 238 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-06-24Application Proof
紫讯技术(福建)股份有限公司Zixun Technology (Fujian) Co., Ltd.

可赎回优先股赎回负债及公允价值变动

Our redemption liabilities amounted to RMB509.2 million, RMB597.4 million, RMB714.0 million and RMB714.1 million as of December 31, 2023, 2024, and 2025 and April 30, 2026, respectively.

Financial Information · 第 203 页

Upon the [REDACTED], the preferential rights attached to these shares will be automatically terminated, and the corresponding redemption liabilities will be derecognized and reclassified as equity.

Financial Information · 第 203 页

We recorded changes in the carrying amount of the redemption liabilities of RMB124.7 million, RMB88.2 million and RMB177.9 million in 2023, 2024 and 2025.

Financial Information · 第 188 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-06-24Application Proof
岸迈生物科技有限公司EpimAb Biotherapeutics Inc.

可转换可赎回优先股公允价值亏损逾2.3亿元

Our fair value losses on convertible redeemable preferred shares amounted to RMB232.7 million, in 2024, as compared to fair value losses on convertible redeemable preferred shares of RMB25.7 million in 2025, respectively.

Financial Information · 第 240 页

Convertible redeemable preferred shares amounted to RMB2,747.1 million and RMB2,772.8 million as of December 31, 2024 and 2025, respectively.

Financial Information · 第 250 页

Our fair value losses on convertible redeemable preferred shares decreased from RMB232.7 million in 2024 to RMB25.7 million in 2025, reflecting changes in the fair value of our Preferred Shares.

Financial Information · 第 242 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-06-24Application Proof
极豪科技(天津)股份有限公司JIIOV Technology (Tianjin) Co., Ltd.

赎回负债账面值变动致各年度亏损

We recorded changes in the carrying amount of redemption liabilities of negative RMB19.0 million, negative RMB18.1 million and negative RMB28.7 million in 2023, 2024 and 2025, respectively.

Financial Information · 第 190 页

Such financial liabilities are measured at the higher of: (i) the investment amount paid by the investors plus an annual simple interest rate of 8% for the period commencing from the investment payment date to the redemption settlement date; and (ii) the fair value of the Company corresponding to the proportion of registered capital put by the investors.

Financial Information · 第 190 页

The redemption liabilities will be reclassified from liabilities to equity upon [REDACTED].

Financial Information · 第 190 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-06-22Application Proof
太合音乐集团Taihe Music Group

可转换可赎回优先股公允价值亏损及上市转换

During the Track Record Period, we recognized fair value changes of convertible redeemable preferred shares of RMB55.0 million, RMB35.4 million and RMB14.0 million in 2023, 2024 and 2025, respectively, representing losses recorded in our consolidated statements of profit or loss.

Financial Information · 第 202 页

The convertible redeemable preferred shares will be automatically converted into Ordinary Shares immediately before the closing of the [REDACTED], and accordingly no further fair value changes will be recognized after the [REDACTED].

Financial Information · 第 202 页

Our convertible redeemable preferred shares amounted to RMB1,574.9 million, RMB1,634.1 million and RMB1,611.7 million as of December 31, 2023, 2024 and 2025, respectively.

Financial Information · 第 215 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-06-22Prospectus
浙江来福谐波传动股份有限公司Zhejiang Laifual Drive Co., Ltd.03952.HK

赎回负债高达12.07亿元并于上市时转股

We had redemption liabilities of RMB917.3 million, RMB1,062.4 million, RMB1,207.4 million and RMB818.1 million as of December 31, 2023, 2024 and 2025 and April 30, 2026, respectively.

Financial Information · 第 242 页

We recognized our obligation to pay cash to those investors with redemption right as financial liabilities, because not all triggering events in the relevant agreements are within our control.

Financial Information · 第 242 页

We had change in the carrying amount of redemption liabilities of RMB145.1 million, RMB145.1 million and RMB145.1 million in 2023, 2024 and 2025, respectively.

Financial Information · 第 226 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-06-18Prospectus
白鸽在线(厦门)数字科技股份有限公司Baige Online Digital Technology Co., Ltd.02672.HK

或有可赎回优先股负债及修改收益

our puttable shares liabilities will be re-designated from liabilities to equity as a result of the automatic conversion into ordinary shares and our position of net current liabilities would turn into net current assets upon Listing.

Financial Information · 第 306 页

Upon the execution of shareholders’ agreement following series B financing, the agreed return rate payable by the Company for previously issued contingently redeemable preferred shares upon exercise of repurchase right was reduced, we therefore recognized a gain on modification of puttable shares liabilities in 2023.

Financial Information · 第 295 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-06-18Application Proof
数说故事人工智能科技股份有限公司DataStory Artificial Intelligence Technology Co., Ltd.

赎回权负债利息每年约5,000万元

We define adjusted net profit/(loss) as loss for the year/period adjusted by adding back (i) [REDACTED], which are expenses incurred in relation to this [REDACTED], (ii) share-based payment expenses, which are primarily non-cash in nature, and (iii) interest on redemption right liabilities, which is related to the preferential rights granted to certain Pre-[REDACTED] Investors and is non-cash in nature, and the redemption right liabilities will be reclassified to equity of our Company upon the completion of the [REDACTED].

Summary · 第 8 页

Interest on redemption right liabilities relates to the preferential rights granted to certain Pre-[REDACTED] Investors and is non-cash in nature, and the redemption right liabilities will be re-classified to equity of our Company upon the completion of the [REDACTED].

Financial Information · 第 204 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-06-18Prospectus
礼邦医药(江苏)股份有限公司Alebund Pharmaceuticals (Jiangsu) Limited09637.HK

普通股赎回负债及2025年9月终止赎回权

Our redemption liabilities on ordinary shares decreased from RMB1,712.6 million as of December 31, 2024 to nil as of December 31, 2025, primarily due to the irrevocable termination of the general redemption rights granted to the shareholders and the redemption liabilities on ordinary shares were credited to other reserve.

Financial Information · 第 259 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-06-17Application Proof
聚慧食品科技有限公司Juhui Food Technology Co., Ltd

优先股公允价值变动及回购影响业绩

Our other gains/losses, net primarily consisted of fair value gains/(losses) on financial assets at fair value through profit or loss (FVTPL), fair value gains/(losses) on financial liabilities at FVTPL, gains/(losses) on disposal of property, plant and equipment, and donations.

Financial Information · 第 173 页

Our net other gains decreased by 85.3% from RMB12.8 million in 2024 to RMB1.9 million in 2025, primarily attributable to repurchase of preferred shares in 2025.

Financial Information · 第 179 页

We recorded net gains of RMB12.8 million in 2024 as compared to net losses of RMB7.5 million in 2023, primarily attributable to repurchase of preferred shares in 2024.

Financial Information · 第 181 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-06-17Application Proof
北京融信数联科技股份有限公司Beijing Rongxin Datainfo Science and Technology Co., Ltd.

Pre-IPO可赎回负债及公允价值变动

Our redemption liabilities arise from the redemption right granted to our Pre-[REDACTED] Investors, which amounted to RMB214.2 million, RMB214.4 million and RMB218.3 million as at December 31, 2023, 2024 and 2025, respectively.

Financial Information · 第 232 页

We recorded fair value changes of our redemption liabilities of RMB3.2 million, RMB0.3 million and RMB3.9 million in FY2023, FY2024 and FY2025, respectively, arising from the redemption rights granted to our Pre-[REDACTED] Investors.

Financial Information · 第 214 页

Under this agreement, all the Special Rights are terminated effective on the date of signature.

Financial Information · 第 200 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-06-17Application Proof
巴奴国际控股有限公司BANU INTERNATIONAL HOLDING LTD

可赎回可转换优先股及赎回负债

As of December 31, 2023, 2024, 2025 and April 30, 2026, our redemption liabilities were RMB327.1 million, RMB301.5 million, RMB320.1 million and RMB326.3 million, respectively.

Financial Information · 第 229 页

In 2023, 2024 and 2025, changes in carrying amount of redemption liabilities were RMB23.7 million, RMB21.1 million and RMB18.6 million, respectively, accounting for 1.1%, 0.9% and 0.7% of our total revenue in the same years, respectively.

Financial Information · 第 214 页

Under this conversion feature, all preferred rights of the holders of preferred shares will be terminated and the preferred shares will be automatically converted into ordinary shares upon the completion of the [REDACTED].

Financial Information · 第 229 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-06-16Application Proof

优先权利赎回负债产生大额融资成本

Our redemption liabilities primarily relate to our obligations arising from certain redemption rights and liquidation preferences granted to the holders of preferred rights in connection with our historical equity financing activities.

Financial Information · 第 207 页

During the Track Record Period, we recognized finance costs arising from redemption liabilities of approximately RMB32.1 million, RMB32.2 million and RMB12.6 million for the years ended December 31, 2023, 2024 and 2025, respectively.

Financial Information · 第 207 页

In May 2025, we entered into a preferred rights termination agreement with the preferred shareholders, pursuant to which the agreed redemption was terminated, and the redemption liabilities were derecognized after entering into such agreement.

Financial Information · 第 208 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-06-16Application Proof

可转换优先股公允价值变动损益

In 2023, we recorded a fair value gain of RMB361.9 million, primarily due to a decrease in the fair value of the convertible preferred shares.

Financial Information · 第 204 页

In 2024 and 2025, we recorded fair value losses of RMB29.1 million and RMB67.4 million, respectively, primarily due to an increase in the fair value of such instruments.

Financial Information · 第 204 页

The Series A Preferred Shares will be automatically converted into ordinary shares upon completion of the [REDACTED], and we do not expect to record further gains or losses in relation to valuation changes in such instruments after the [REDACTED].

Financial Information · 第 204 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-06-15Application Proof

赎回负债约28亿元及其账面值变动计入损益

From 2021 to 2023, we entered into certain financing agreements with several investors, pursuant to which we issued our share capital, facilitated the transfer of shares by certain original shareholders, and granted investors certain special rights.

Financial Information · 第 228 页

We recognized redemption liabilities of RMB2,418.0 million, RMB2,623.7 million and RMB2,823.0 million as of December 31, 2023, 2024 and 2025, respectively.

Summary · 第 9 页

Our changes in carrying amount of redemption liabilities amounted to RMB195.9 million, RMB205.7 million and RMB206.1 million, in 2023, 2024 and 2025, respectively.

Financial Information · 第 211 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-06-15Prospectus
陕西麦科奥特医药科技股份有限公司Shaanxi Micot Pharmaceutical Technology Co., Ltd.02335.HK

Pre-IPO投资产生逾11亿元赎回负债

As of December 31, 2024, December 31, 2025 and April 30, 2026, our redemption liabilities, which were unsecured and unguaranteed, amounted to nil, RMB1,159 million and RMB1,202 million, respectively.

Financial Information · 第 267 页

Our redemption liabilities primarily represent our obligation to purchase our equity instruments, which is conditional on the exercise by certain investors of the right to require their investments to be redeemed.

Financial Information · 第 267 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看

Tell us